Lucy Burr

VX-445–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles

D. Keating, Gautham Marigowda, Lucy Burr et al. · New England Journal of Medicine · 2018 · 707 citations · Full text

A Novel Microbiota Stratification System Predicts Future Exacerbations in Bronchiectasis

Geraint B. Rogers, Nur Masirah M. Zain, Kenneth D. Bruce et al. · Annals of the American Thoracic Society · 2014 · 232 citations

The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial

Geraint B. Rogers, Kenneth D. Bruce, Megan Martin et al. · The Lancet Respiratory Medicine · 2014 · 226 citations

Respiratory Microbiota Composition, Non-cystic Fibrosis Bronchiectasis, Placebo-controlled Bless Trial +8

<i>R</i><i>othia mucilaginosa</i>is an anti-inflammatory bacterium in the respiratory tract of patients with chronic lung disease

Charlotte Rigauts, Juliana Aizawa, Steven Taylor et al. · European Respiratory Journal · 2021 · 150 citations · Full text

Airway Mucus Hyperconcentration in Non–Cystic Fibrosis Bronchiectasis

Kathryn Ramsey, Alice C.–H. Chen, Giorgia Radicioni et al. · American Journal of Respiratory and Critical Care Medicine · 2019 · 125 citations · Full text